Tazemetostat hydrobromide
| CAS No. | 1467052-75-0 | Cat. No. | BCP39175 |
| Name | Tazemetostat hydrobromide | ||
| Synonyms | EPZ-6438 HBr; EPZ 6438 HBr; EPZ6438; E7438; E-7438; E 7438; | ||
| Formula | C34H45BrN4O4 | M. Wt | 653.66 |
| Description | Tazemetostat is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. Treatment of xenograft-bearing mice with EPZ-6438 leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation. These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymatic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers. | ||
| Pathways | Epigenetics | ||
| Targets | Histone Methyltransferase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.